COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.704110
Abstract: Patients diagnosed with malignancy, neurological and immunological disorders, i.e., fragile patients, have been excluded from COVID-19 vaccine trials. However, this population may present immune response abnormalities, and relative reduced vaccine responsiveness. Here we review the… read more here.
Keywords: current evidence; covid vaccination; fragile patients; vaccination fragile ... See more keywords